Loading company…
Pro-Med, based in Linz, Austria, develops the SmartDose® On-Body Delivery System for self-administering medicines such as biologics.
Founded in 1997 in Linz, Austria, Pro-Med develops drug delivery systems, notably the SmartDose® On-Body Delivery System, launched in 2010, which lets patients self-administer medicines such as biologics. It sells mainly to pharmaceutical and biotechnology companies under B2B contracts. In June 2004 it raised EUR 3 million in a Series B round from GCP Gamma Capital Partners and Sofinnova Partners, its second deal.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in